Axsome Therapeutics, Inc. (AXSM)

169.38 +1.83 (+1.09%) USD  |  NASDAQ  |  Jan 09, 16:00
174.19 +4.81 (+2.84%) Pre-Market: 08:50
More

Axsome Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
Innoviva, Inc. Upgrade